Taro Matsumoto

Prof. Taro Matsumoto

Professor, Department of Functional Morphology, Division of Cell Regeneration and Transplantation
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in Tissue Engineering Part A
Verified
Journal Article
Closed access
SKShinsuke Kikuta
Shinsuke Kikuta
NTNobuaki Tanaka
Nobuaki Tanaka
TKTomohiko Kazama
Tomohiko Kazama
MKMinako Kazama
Minako Kazama
KKKoichiro Kano
Koichiro Kano
TMTaro Matsumoto
Taro Matsumoto
We have previously reported that mature adipocyte-derived dedifferentiated fat (DFAT) cells have a high proliferative activity and the potential to differentiate into lineages of mesenchymal tissue similar to bone marrow mesenchymal stem cells (MSCs). In the present study, we examined the effects of autologous DFAT cell transplantation on bone regeneration in a rabbit bone defect model and an ovariectomy (OVX)-induced osteoporosis model. The formation of tissue-engineered bone (TEB) was observed when rabbit DFAT cells were loaded onto a β-tricalcium phosphate (TCP)/collagen sponge and cultured in an osteogenic differentiation medium for 3 weeks. Autologous implantation of DFAT cell-mediated TEB constructs promoted bone regeneration in a rabbit tibial defect model. Regenerated bone tissue induced by transplantation of DFAT cell-mediated TEB constructs was histologically well differentiated and exhibited higher bone strength in a three-point bending test compared to that induced by the β-TCP/collagen sponge alone. In OVX-induced osteoporosis model rabbits, DFAT cells were obtained with the osteogenic activity similar to cells from healthy rabbits. Intrabone marrow injection of autologous DFAT cells significantly increased the bone mineral density (BMD) at the injected site in the OVX rabbits. Transplanted DFAT cells remained mainly on the injection side of the bone marrow by at least 28 days after intrabone marrow injection and a part of them expressed osteocalcin. In conclusion, these results demonstrate that autologous implantation of DFAT cells contributed to bone regeneration in a rabbit bone defect model and an OVX-induced osteoporosis model. DFAT cells may be an attractive cell source for cell-based bone tissue engineering to treat nonunion fractures in all patients, including those with osteoporosis.

12 October 2011 in International Journal of Urology
Verified
Journal Article
Closed access
PDF file
DODaisuke Obinata
Daisuke Obinata
TMTaro Matsumoto
Taro Matsumoto
YIYuichiro Ikado
Yuichiro Ikado
TSTakahiro Sakuma
Takahiro Sakuma
KKKoichiro Kano
Koichiro Kano
STSatoru Takahashi
Satoru Takahashi

1 October 2017 in Atherosclerosis
Verified
Journal Article
Closed access
MSMitsumasa Sudo
Mitsumasa Sudo
YLYuxin Li
Yuxin Li
THTakafumi Hiro
Takafumi Hiro
TTTadateru Takayama
Tadateru Takayama
MMMasako Mitsumata
Masako Mitsumata
AHAtsushi Hirayama
Atsushi Hirayama

1 January 2014 in The Veterinary Journal
Verified
Journal Article
Closed access
SKShota Kono
Shota Kono
TKTomohiko Kazama
Tomohiko Kazama
KKKoichiro Kano
Koichiro Kano
KHKayoko Harada
Kayoko Harada
MUMasami Uechi
Masami Uechi
TMTaro Matsumoto
Taro Matsumoto

8 June 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HWHirofumi Watanabe
Hirofumi Watanabe
SGShumpei Goto
Shumpei Goto
RKReona Kato
Reona Kato
SKShogo Komiyama
Shogo Komiyama
YNYuki Nagaoka
Yuki Nagaoka
TMTaro Matsumoto
Taro Matsumoto
Mature adipocyte-derived dedifferentiated fat (DFAT) cells can be prepared efficiently and with minimal invasiveness to the donor. They can be utilized as a source of transplanted cells during therapy. Although the transplantation of DFAT cells into an ischemic tissue enhances angiogenesis and increases vascular flow, there is little information regarding the mechanism of the therapeutic angiogenesis. To further study this, mice ischemic hindlimb model was used. It was confirmed that in comparison with the adipose derived stem cells and fibroblasts, the transplantation of DFAT cells led to a significant improvement in the blood flow and increased mature blood vessel density. The ability of DFAT cells to secrete angiogenic factors in hypoxic conditions and upon co-culture with vascular endothelial cells was then examined. Furthermore, we examined the possibility that DFAT cells differentiating into pericytes. The therapeutic angiogenic effects of DFAT cells were observed by the secretion of angiogenic factors and pericyte differentiation by transforming growth factor β1 signalling via Smad2/3. DFAT cells can be prepared with minimal invasiveness and high efficiency and are expected to become a source of transplanted cells in the future of angiogenic cell therapy.

1 July 2018 in Journal of Orthopaedic Science
Verified
Journal Article
Open access
MSManabu Shimizu
Manabu Shimizu
TMTaro Matsumoto
Taro Matsumoto
SKShinsuke Kikuta
Shinsuke Kikuta
MOMunenori Ohtaki
Munenori Ohtaki
KKKoichiro Kano
Koichiro Kano
YTYasuaki Tokuhashi
Yasuaki Tokuhashi
Mature adipocyte-derived dedifferentiated fat (DFAT) cells possesses the ability to proliferate effectively and the potential to differentiate into multiple linages of mesenchymal tissue; similar to adipose-derived stem cells (ASCs). The purpose of this study is to examine the effects of DFAT cell transplantation on cartilage repair in a rat model of osteochondral defects. Full-thickness osteochondral defects were created in the knees of Sprague-Dawley rats bilaterally. Cartilage-like micromass pellets were prepared from green fluorescent protein (GFP)-labeled rat DFAT cells and subsequently transplanted into the affected right knee of these rats. Defects in the left knee were used as a control. Macroscopic and microscopic changes of treated and control defects were evaluated up to 12 weeks post-treatment with DFAT cells. To observe the transplanted cells, sectioned femurs were immunostained for GFP and type II collagen. DFAT cells formed micromass pellets expressing characteristics of immature cartilage in vitro. In the DFAT cell-transplanted limbs, the defects were completely filled with white micromass pellets as early as 2 weeks post-treatment. These limbs became smooth at 4 weeks. Conversely, the defects in the control limbs were still not repaired by 4 weeks. Macroscopic ICRS scores at 2 and 4 weeks were significantly higher in the DFAT cells-transplanted limbs compared to those of the control limbs. The modified O'Driscol histological scores for the DFAT cell-transplanted limbs were significantly higher than those of the control limbs at corresponding time points. GFP-positive DAFT cells were detected in the transplanted area at 2 weeks but hardly visible at 12 weeks post-operation. Transplantation of DFAT cell-derived micromass pellets contribute to cartilage repair in a rat osteochondral defect model. DFAT cell transplantation may be a viable therapeutic strategy for the repair of osteochondral injuries.